LLY

976.43

-1.67%↓

JNJ

222.34

-0.53%↓

ABBV

202.95

-0.89%↓

UNH

367.82

+0.13%↑

AZN

182.55

-1.35%↓

LLY

976.43

-1.67%↓

JNJ

222.34

-0.53%↓

ABBV

202.95

-0.89%↓

UNH

367.82

+0.13%↑

AZN

182.55

-1.35%↓

LLY

976.43

-1.67%↓

JNJ

222.34

-0.53%↓

ABBV

202.95

-0.89%↓

UNH

367.82

+0.13%↑

AZN

182.55

-1.35%↓

LLY

976.43

-1.67%↓

JNJ

222.34

-0.53%↓

ABBV

202.95

-0.89%↓

UNH

367.82

+0.13%↑

AZN

182.55

-1.35%↓

LLY

976.43

-1.67%↓

JNJ

222.34

-0.53%↓

ABBV

202.95

-0.89%↓

UNH

367.82

+0.13%↑

AZN

182.55

-1.35%↓

Search

Bio-Rad Laboratories Inc

Open

SectorGezondheidszorg

256.87 -1.89

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

256

Max

262.77

Belangrijke statistieken

By Trading Economics

Inkomsten

-731M

-11M

Verkoop

-101M

592M

K/W

Sectorgemiddelde

42.763

49.8

EPS

1.89

Winstmarge

-1.858

Werknemers

7,450

EBITDA

-792M

-678M

Aanbevelingen

By TipRanks

Aanbevelingen

Buy

12 Maanden Prognose

+19.04% upside

Dividenden

By Dow Jones

Volgende Winsten

30 jul 2026

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-795M

7B

Vorige openingsprijs

258.76

Vorige sluitingsprijs

256.87

Nieuwssentiment

By Acuity

50%

50%

187 / 347 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Very Strong Bearish Evidence

Bio-Rad Laboratories Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

31 jul 2025, 23:56 UTC

Populaire aandelen

Stocks to Watch: Amazon, Bio-Rad, Coinbase, Mercer

Peer Vergelijking

Prijswijziging

Bio-Rad Laboratories Inc Prognose

Koersdoel

By TipRanks

19.04% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 308.33 USD  19.04%

Hoogste 335 USD

Laagste 290 USD

Gebaseerd op 3 Wall Street-analisten die 12-maands prijsdoelen bieden voor Bio-Rad Laboratories Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

3 ratings

1

Buy

2

Hold

0

Sell

Technische score

By Trading Central

229.835 / 235.8095Steun & Weerstand

Korte Termijn

Very Strong Bearish Evidence

Gemiddeld Termijn

Bullish Evidence

Lange Termijn

Bearish Evidence

Sentiment

By Acuity

187 / 347 Rangschikking in Gezondheidszorg

Nieuwssentiment

Neutral

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Bio-Rad Laboratories Inc

Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials such as cells, proteins, and nucleic acids for proteomics, genomics, biopharmaceutical production, cellular biology, and food safety markets. It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, transfusion, and physician office laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
help-icon Live chat